Former B.C. resident participating in AstraZeneca COVID-19 vaccine trial - Global News | Canada News Media
Connect with us

Business

Former B.C. resident participating in AstraZeneca COVID-19 vaccine trial – Global News

Published

 on


A former Vancouver resident is sharing his first-hand experience as one of the thousands of people who’ve agreed to participate in COVID-19 vaccine trials around the world.

Peter Wearing, who now lives in Arizona, is participating in the Stage 3 trial for the Oxford University-AstraZeneca vaccine.

The U.K.-based drug maker’s vaccine is seen as an important part of the vaccine solution, as it does not need to be transported at supercooled temperatures, and is being offered at a fraction of the price of its rivals.

Read more:
AstraZeneca releases coronavirus vaccine data. Here’s what Canadians should know

Both elements make it particularly promising for the developing world.

“I felt that I was healthy and I’ve had vaccines in the past and never had adverse reactions, so I felt that I’ll do my part,” Wearing told Global News.

Story continues below advertisement






2:51
Canadian in charge of Moderna’s international vaccine manufacturing


Canadian in charge of Moderna’s international vaccine manufacturing

“My first visit I signed lots of paperwork, they took four vials of blood, I had a physical from a doctor.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

He was then given two shots, two months apart — the second just two days ago. Wearing isn’t sure if he’s getting the actual vaccine, or is in a control group getting a placebo.

He said some people do get reactions typical of a flu vaccine, such as rashes or fevers, but he did not.

Read more:
AstraZeneca COVID-19 vaccine manufacturing error raises questions

“You don’t even really feel it going in, it’s that fine of a needle. The next day your muscle is a bit tender,” he said.

Story continues below advertisement

Oxford and AstraZeneca reported in November that their vaccine appeared to be 62 per cent effective in people who received two doses, and 90 per cent effective when volunteers were given a half dose followed by a full dose.






2:02
Federal government, provinces and Canadian Armed Forces ramp up COVID-19 vaccine rollout plan


Federal government, provinces and Canadian Armed Forces ramp up COVID-19 vaccine rollout plan

It later emerged that they’d discovered the half-dose advantage due to a manufacturing error that saw some people get a lower dose unintentionally. The company may conduct a future clinical trial specifically around the half-then-full dose program.

Wearing said it was important for him to participate because he still remembers an era when children commonly got polio. Vaccine development was critical to eradicating that disease.

“I have a lot of friends that are anti-vaxxers. I mean, they’re pretty serious about it, they’ve even challenged me on this,” he said.

“About five years ago I took the time to read what they said is their research, and then I read the counter-research. I’m a science guy, I like science, and in the end I came down on the side of traditional science.”

Story continues below advertisement

Wearing said he’s given a two-year commitment to the project, and doctors will continue to take blood samples to test Wearing for antibodies to the virus.

Read more:
B.C. reports 711 new COVID-19 cases, 11 deaths

But he’s also been told that if he is, in fact, in the placebo group he will be given the actual vaccine if and when it wins approval in the U.S.

“The fact that this is coming out so fast, less than a year, is really exciting,” he said.

Canada has preordered 20 million doses of the AstraZeneca vaccine, but it is unclear when it could win regulatory approval.

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version